688221 前沿生物
按盤價 
15.820 -3.090 (-16.341%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -8.910 | -16.214 | -21.828 | -20.377 | -13.090 |
| 總資產報酬率 ROA (%) | -5.602 | -10.191 | -14.457 | -14.434 | -10.301 |
| 投入資產回報率 ROIC (%) | -6.050 | -11.013 | -15.867 | -15.742 | -11.050 | 邊際利潤分析 |
| 銷售毛利率 (%) | 30.989 | 33.927 | 28.995 | 18.605 | -30.438 |
| 營業利潤率 (%) | -165.670 | -155.317 | -286.857 | -421.616 | -660.429 |
| 息稅前利潤/營業總收入 (%) | -167.538 | -149.998 | -281.255 | -421.061 | -667.212 |
| 淨利潤/營業總收入 (%) | -166.018 | -155.540 | -287.935 | -421.008 | -654.939 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.264 | 137.158 | 106.828 | 111.148 | 119.975 |
| 價值變動淨收益/利潤總額(%) | 2.218 | -41.799 | -5.065 | -5.590 | -14.330 |
| 營業外收支淨額/利潤總額(%) | 0.210 | 0.144 | 0.374 | -0.144 | -0.838 | 償債能力分析 |
| 流動比率 (X) | 2.882 | 3.094 | 2.901 | 5.072 | 3.949 |
| 速動比率 (X) | 2.716 | 2.990 | 2.746 | 4.871 | 3.852 |
| 資產負債率 (%) | 37.232 | 37.019 | 37.262 | 30.670 | 27.734 |
| 帶息債務/全部投入資本 (%) | 18.998 | 20.972 | 14.050 | 7.587 | 9.575 |
| 股東權益/帶息債務 (%) | 360.212 | 321.530 | 486.436 | 1,009.651 | 813.142 |
| 股東權益/負債合計 (%) | 168.586 | 170.135 | 168.373 | 226.052 | 260.565 |
| 利息保障倍數 (X) | 110.251 | -27.062 | -42.107 | 7,917.325 | 54.367 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 122.604 | 135.910 | 156.202 | 124.219 | 240.922 |
| 存貨周轉天數 (天) | 229.331 | 210.543 | 254.308 | 245.900 | 177.669 |
| 備註： | 即時報價更新時間為 05/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
